Mannheimia Haemolytica Type A1, Nl-1009, Capsular Antigen, Kb; Mannheimia Haemol
59 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
59
Total Reports
51
Deaths Reported
8640.0%
Death Rate
Active Ingredients
Mannheimia Haemolytica Type A1, Nl-1009, Capsular Antigen, Kb; Mannheimia Haemol
Administration Routes
Subcutaneous
Species Affected
Cattle 59
Most Affected Breeds
Cattle (other) 40
Crossbred Bovine/Cattle 7
Aberdeen Angus 4
Cattle (unknown) 2
Holstein-Friesian also known as Holstein 2
Mixed (Cattle) 2
Cattle (unspecified) 1
Charolais 1
Most Reported Reactions
Lack of efficacy (bacteria) - NOS 52
Death 38
Lack of efficacy - NOS 10
CULTURE/TITER DATA ABNORMAL 9
Increased mortality rate 6
Abnormal test result 5
DEATH-TREATMENT FAILURE 4
Death by euthanasia 3
Lack of efficacy (protozoa) - Coccidia 3
PR-LUNG(S), LESION(S) 3
Fever 3
Pneumonia 2
Outcome Breakdown
Died
50 (47.2%)
Outcome Unknown
36 (34.0%)
Recovered/Normal
9 (8.5%)
Ongoing
7 (6.6%)
Euthanized
2 (1.9%)
Recovered with Sequela
2 (1.9%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.